Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Harmon Cyrus Create: Alert

All | News | Filings
Date FiledTypeDescription
11/20/2020 4/A Harmon Cyrus (Chief Technology Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.
Txns: Granted 1,076 options to buy @ $19, valued at $20.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy